Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib-Reference-Cited by-同舟云学术

Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib

Published:2006-05 Issue:2 Volume:52 Page:253-255
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Nakatomi Katsumi,Soda Hiroshi,Kitazaki Takeshi,Nakano Hirofumi,Uchida Kanako,Urabe Sou,Nakamura Yoichi,Hayashi Tomayoshi,Tsukamoto Kazuhiro,Kohno Shigeru

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference9 articles.

1. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions;Pao;J Clin Oncol,2005

2. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomized, placebo-controlled, multicentre study (Iressa survival evaluation in lung cancer);Thatcher;Lancet,2005

3. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004

4. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence;Mitsudomi;J Clin Oncol,2005

5. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib;Han;J Clin Oncol,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study;Therapeutic Advances in Medical Oncology;2021-01

2. Long-lasting response to afatinib that persisted after treatment discontinuation in a case ofEGFR-mutated lung adenocarcinoma;BMJ Case Reports;2019-01

3. 10-year long-term survival of a metastaticEGFR-mutated nonsmall cell lung cancer patient;European Respiratory Journal;2015-04-16

4. High efficacy of gefitinib in the treatment of EGFR mutation-positive advanced non-small cell lung adenocarcinoma: A case report;Oncology Letters;2014-06-19

5. Long-Term Treatment with Erlotinib for EGFR Wild-Type Non-Small Cell Lung Cancer: A Case Report;Case Reports in Oncology;2013